Updated: January 23, 2026
Yusimry Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

Summarize with AI
Learn about common and serious Yusimry (adalimumab-aqvh) side effects, what to watch for, and when to contact your doctor — including the black box warning explained.
Like all medications, Yusimry (adalimumab-aqvh) can cause side effects. Because it works by suppressing part of your immune system — specifically by blocking tumor necrosis factor (TNF-alpha) — the most important side effects involve infection risk and certain types of cancer. Most patients tolerate Yusimry well, but knowing what to watch for can help you respond quickly if something goes wrong.
The Black Box Warning: Serious Infections and Malignancy
Yusimry carries an FDA black box warning — the most serious type of medication warning — for two main risks:
Serious Infections: Yusimry increases the risk of serious infections that may lead to hospitalization or death. These include tuberculosis (TB), bacterial sepsis, invasive fungal infections (such as histoplasmosis), and other opportunistic infections. You should not start Yusimry during an active infection. Stop taking it and call your doctor immediately if you develop fever, persistent cough, or other signs of infection.
Malignancy: Lymphoma and other cancers — some fatal — have been reported in children and adolescents treated with TNF blockers including adalimumab products. In clinical trials, there was an approximately 3-fold higher rate of lymphoma in adalimumab-treated patients compared to the general U.S. population. Non-melanoma skin cancers were also more common.
Common Side Effects of Yusimry
These are the most frequently reported side effects — most are mild to moderate:
Injection site reactions — redness, itching, pain, swelling, or bruising at the injection site. This is the most common side effect, occurring in about 20% of patients in clinical trials. Most reactions are mild and resolve on their own.
Upper respiratory infections — sinusitis, sore throat, and common cold-like symptoms.
Headache
Rash — mild skin reactions unrelated to the injection site.
Nausea
Serious Side Effects: When to Call Your Doctor Immediately
Contact your doctor or seek emergency care immediately if you experience:
Signs of serious infection: Fever, chills, persistent cough, shortness of breath, painful urination, warm or red skin sores, or extreme fatigue.
Signs of TB reactivation: Persistent cough, night sweats, unexplained weight loss, fatigue.
Signs of heart failure (new or worsening): Shortness of breath, sudden weight gain, or swelling in the legs or ankles.
Nervous system problems: Numbness or tingling, vision changes, dizziness, or weakness in arms or legs (which may indicate demyelinating disease).
Blood problems: Persistent fever, bruising, bleeding, or pallor — which may indicate blood dyscrasias including pancytopenia or aplastic anemia.
Allergic reactions: Difficulty breathing, hives, or rapid heartbeat after injection — may indicate anaphylaxis, a rare but serious emergency.
Lupus-like symptoms: Joint pain, chest pain, or a butterfly-shaped rash on the face.
Hepatitis B Reactivation Risk
If you are a hepatitis B (HBV) carrier, Yusimry can reactivate the virus — in some cases fatally. Your doctor should test you for HBV before starting Yusimry. If you're a carrier, careful monitoring is required, and antiviral therapy may be needed. Tell your doctor about any history of hepatitis B.
Tips for Reducing Injection Site Reactions
Let Yusimry warm to room temperature for 15-30 minutes before injecting
Rotate injection sites (thighs and abdomen are common locations)
Do not inject into skin that is bruised, tender, red, or hard
Do not rub the injection site after the shot — this can worsen bruising
For more information on drug interactions with Yusimry, see our guide: Yusimry Drug Interactions. If you're struggling to fill your Yusimry prescription, medfinder can help you find pharmacies with it in stock.
Frequently Asked Questions
The most common side effect is injection site reactions — redness, itching, pain, or swelling — occurring in about 20% of patients. Upper respiratory infections, headache, rash, and nausea are also commonly reported. Most side effects are mild to moderate and don't require stopping the medication.
Yusimry carries an FDA black box warning for two serious risks: (1) serious infections including tuberculosis, bacterial sepsis, and invasive fungal infections that may lead to hospitalization or death, and (2) malignancy — lymphoma and other cancers have been reported, particularly in children and adolescents treated with TNF blockers.
Let Yusimry warm to room temperature for 15-30 minutes before injecting. Rotate injection sites between your thighs and abdomen. Do not rub the injection site after the shot. Apply a cold pack to the area before injection to reduce pain sensitivity.
In clinical trials, patients treated with adalimumab products (including biosimilars like Yusimry) had approximately a 3-fold higher rate of lymphoma than the general US population. Non-melanoma skin cancers were also more common. However, the absolute risk remains relatively low, and patients with serious autoimmune diseases may already have elevated cancer risk from their condition and prior treatments.
Contact your doctor immediately if you develop signs of infection — fever, chills, persistent cough, warm or red skin sores, or fatigue. Do not take another dose of Yusimry until your doctor evaluates you. If serious infection is confirmed, you will need to stop Yusimry until the infection is fully treated and resolved.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Yusimry also looked for:
More about Yusimry
30,682 have already found their meds with Medfinder.
Start your search today.





